Virbac SA (0NM7.IL)
IOB · EUR · Healthcare · Drug Manufacturers - General
€348.25 (-0.29%) as of
Key statistics
- Market cap
- 2.97B
- P/E (TTM)
- 24.89
- EPS (TTM)
- 13.99
- Dividend yield
- 0.52%
- 52-week range
- 297.00 – 385.50
- Beta
- 0.90
- Revenue (TTM)
- 1.21B
- Profit margin
- 9.87%
About Virbac SA
Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Headquarters
- Carros, France
- Employees
- 5,386
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.